Author:
Makiyama Akitaka,Kunieda Kenji,Noguchi Masaaki,Kajiwara Takeshi,Tamura Takao,Takeda Koji,Sugiyama Junko,Minashi Keiko,Moriwaki Toshikazu,Sugimoto Naotoshi,Nagase Michitaka,Negoro Yuji,Tsuda Takashi,Shimodaira Hideki,Okano Naohiro,Tsuji Akihito,Sakai Daisuke,Yanagihara Kazuhiro,Ueda Shinya,Tamura Shingo,Otsu Satoshi,Honda Takuya,Matsushita Yuzo,Okuno Tatsuya,Kashiwada Tomomi,Nozaki Akira,Ebi Masahide,Okuda Hiroyuki,Shimokawa Mototsugu,Hironaka Shuichi,Hyodo Ichinosuke,Baba Eishi,Boku Narikazu,Muro Kei,Esaki Taito
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Gastroenterology,Oncology,General Medicine
Reference18 articles.
1. Ferlay J, Bray F, Parkin DM, Pisani P, editors. Globocan 2000: cancer incidence and mortality worldwide (IARC Cancer Bases No. 5). Lyon: IARC Press; 2001.
2. Cancer Statistics in Japan. Foundation for promotion of cancer research. 2010. http://ganjoho.ncc.go.jp/public/statistics/backnumber/2010_en.html . Accessed 1 Oct 2015.
3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Older Adult Oncology (version 2. 2017).
4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer (version 5.2017).
5. Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10:1063–9.